132 related articles for article (PubMed ID: 10588626)
1. IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice.
Chmiel JF; Konstan MW; Knesebeck JE; Hilliard JB; Bonfield TL; Dawson DV; Berger M
Am J Respir Crit Care Med; 1999 Dec; 160(6):2040-7. PubMed ID: 10588626
[TBL] [Abstract][Full Text] [Related]
2. Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice.
Chmiel JF; Konstan MW; Saadane A; Krenicky JE; Lester Kirchner H; Berger M
Am J Respir Crit Care Med; 2002 Apr; 165(8):1176-81. PubMed ID: 11956064
[TBL] [Abstract][Full Text] [Related]
3. Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice.
Saadane A; Soltys J; Berger M
J Allergy Clin Immunol; 2005 Feb; 115(2):405-11. PubMed ID: 15696103
[TBL] [Abstract][Full Text] [Related]
4. Effects of bronchopulmonary inflammation induced by pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in mice.
van Heeckeren A; Ferkol T; Tosi M
Gene Ther; 1998 Mar; 5(3):345-51. PubMed ID: 9614554
[TBL] [Abstract][Full Text] [Related]
5. Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice.
van Heeckeren AM; Tscheikuna J; Walenga RW; Konstan MW; Davis PB; Erokwu B; Haxhiu MA; Ferkol TW
Am J Respir Crit Care Med; 2000 Jan; 161(1):271-9. PubMed ID: 10619831
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokines in cystic fibrosis lungs.
Bonfield TL; Panuska JR; Konstan MW; Hilliard KA; Hilliard JB; Ghnaim H; Berger M
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2111-8. PubMed ID: 8520783
[TBL] [Abstract][Full Text] [Related]
7. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
Saadane A; Soltys J; Berger M
J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
[TBL] [Abstract][Full Text] [Related]
8. Lung function and inflammation during murine Pseudomonas aeruginosa airway infection.
Wölbeling F; Munder A; Kerber-Momot T; Neumann D; Hennig C; Hansen G; Tümmler B; Baumann U
Immunobiology; 2011 Aug; 216(8):901-8. PubMed ID: 21497410
[TBL] [Abstract][Full Text] [Related]
9. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
10. Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.
Palomo J; Marchiol T; Piotet J; Fauconnier L; Robinet M; Reverchon F; Le Bert M; Togbe D; Buijs-Offerman R; Stolarczyk M; Quesniaux VF; Scholte BJ; Ryffel B
PLoS One; 2014; 9(12):e114884. PubMed ID: 25500839
[TBL] [Abstract][Full Text] [Related]
11. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis.
Dakin CJ; Numa AH; Wang H; Morton JR; Vertzyas CC; Henry RL
Am J Respir Crit Care Med; 2002 Apr; 165(7):904-10. PubMed ID: 11934712
[TBL] [Abstract][Full Text] [Related]
12. IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.
Buff SM; Yu H; McCall JN; Caldwell SM; Ferkol TW; Flotte TR; Virella-Lowell IL
Gene Ther; 2010 May; 17(5):567-76. PubMed ID: 20357828
[TBL] [Abstract][Full Text] [Related]
13. Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis.
Konstan MW; Vargo KM; Davis PB
Am Rev Respir Dis; 1990 Jan; 141(1):186-92. PubMed ID: 2153353
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
[TBL] [Abstract][Full Text] [Related]
15. Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice.
van Heeckeren AM; Schluchter MD; Xue W; Davis PB
Am J Respir Crit Care Med; 2006 Feb; 173(3):288-96. PubMed ID: 16272448
[TBL] [Abstract][Full Text] [Related]
16. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.
Ulrich M; Beer I; Braitmaier P; Dierkes M; Kummer F; Krismer B; Schumacher U; Gräpler-Mainka U; Riethmüller J; Jensen PØ; Bjarnsholt T; Høiby N; Bellon G; Döring G
Thorax; 2010 Nov; 65(11):978-84. PubMed ID: 20880875
[TBL] [Abstract][Full Text] [Related]
17. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.
Armstrong DS; Hook SM; Jamsen KM; Nixon GM; Carzino R; Carlin JB; Robertson CF; Grimwood K
Pediatr Pulmonol; 2005 Dec; 40(6):500-10. PubMed ID: 16208679
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
19. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice.
Dubin PJ; Kolls JK
Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L519-28. PubMed ID: 17071720
[TBL] [Abstract][Full Text] [Related]
20. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection.
Tiringer K; Treis A; Fucik P; Gona M; Gruber S; Renner S; Dehlink E; Nachbaur E; Horak F; Jaksch P; Döring G; Crameri R; Jung A; Rochat MK; Hörmann M; Spittler A; Klepetko W; Akdis CA; Szépfalusi Z; Frischer T; Eiwegger T
Am J Respir Crit Care Med; 2013 Mar; 187(6):621-9. PubMed ID: 23306544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
